|Madame Charis ENG||Tweeter|
To be considered for the title of Doctor Honoris Causa at the University of Liege, the candidate must have demonstrated excellence, leadership, novel thinking and a remarkable dedication to their field of study. Dr. ENG surpasses these criteria on many counts, as she is an acknowledged world-renowned scientist, physician and educator who has made fundamental contributions to the way clinical genetics in practiced in medicine around the world. A truly international figure, Prof. ENG’s life and work has spanned the globe from her early life in Asia (Singapore), to her education in Europe (England) and her professional career at the leading medical centres in North America. She is a leader in bringing clinical genomics into the forefront of advanced medical practice today and is a senior academic and clinical figure, who holds important elected positions such as the Institute of Medicine at the US National Academies of Sciences, and has been awarded many important prizes, including the Doris Duke Distinguished Clinical Scientist Award, the American Thyroid Association Van Meter Award, the Ernst Oppenheimer Award of The Endocrine Society, the American Cancer Society Research Medal of Honor, the 2014 James Ewing Lecturer of the Society of Surgical Oncology and the 2014 American Association of Cancer Research Charlotte Friend Memorial Lecturer. She also has served on the Board of Directors of the American Society of Human Genetics, the Board of Scientific Directors of the National Human Genome Research Institute and serves on the Expert Panel of the World Health Organisation Project on Public Health Genomics in Developing Countries.
Dr. Eng grew up in Singapore and Bristol, UK and entered the University of Chicago at the age of 16. She completed her MD and PhD at the Pritzker School of Medicine, University of Chicago and undertook specialization in internal medicine, medical oncology, and clinical genetics variously at Beth Israel Hospital, the Dana-Farber Cancer Institute of Harvard University, and the University of Cambridge, UK. Following increasing professional responsibilities, she was recruited to the Cleveland Clinic in Sept, 2005 where she founded and leads the Genomic Medicine Institute, a single platform for research, academic clinical activities and education in genomics medicine.
Scientifically she has made fundamental discoveries in the genetics and genomics of syndromic and sporadic cancers, including important work on RET testing in multiple endocrine neoplasia type 2, and characterization of Cowden and Cowden-related syndromes associated with PTEN and other mutations. Dr. Eng has published over 400 peer reviewed original papers in such journals as the New England Journal of Medicine, JAMA, Lancet, Nature Genetics, Nature, Cell and Molecular Cell. Her h index is more than 100, and her work has been cited in excess of 35,000 times. Her involvement in science also stretches to important Editorial roles : North American Editor of the Journal of Medical Genetics (1998-2005), Senior Editor of Cancer Research (2004-09), and Associate Editor of the Journal of Clinical Endocrinology and Metabolism (2005-09) and of the American Journal of Human Genetics (2007-09). She is currently the Editor-in-Chief of Endocrine-Related Cancer.
You will understand that Dr. ENG is a world-class scientist and physician whose work continues to impact the understanding of the genetics of disease and their clinical practice. She is an international figure, with experience of life and work that spans the globe and is without any doubt one of the leading women working in medicine and clinical sciences in the world today. Were she to be named Doctor Honoris Causa of the University of liege, it would be a well deserved award for a remarkable physician.
Professor A. BECKERS
Chief, Department of Endocrinology
CHU de Liège